公众号 / 文章重症综合管理与镇静镇痛呼吸衰竭与机械通气消化、代谢与肾脏急症

COVID-19急性期后遗症:认识与应对多系统表现负担

Post-acute sequelae of COVID-19: understanding and addressing the burden of multisystem manifestations.
PubMed 文献 · Lancet Respir Med · 2023-07-17
一句话结论COVID-19重症幸存者面临ARDS、脓毒症和慢性危重症的已知后遗症,可能与SARS-CoV-2特异性效应难以区分,需多系统康复支持。

本文综述成人COVID-19重症后急性期后遗症的表现,包括躯体、认知和精神健康损害,统称长COVID或COVID-19后状态。重症幸存者面临ARDS、脓毒症和慢性危重症的已知后遗症,这些多维病症可能与SARS-CoV-2和COVID-19的特异性效应难以区分。文章探讨对各器官系统的影响、潜在病理生理机制,以及为多系统表现的重症幸存者提供临床照护和支持的挑战。研究需减少COVID-19相关重症急性期后遗症的发生,并优化治疗和康复照护。

要点

  • COVID-19重症幸存者面临ARDS、脓毒症和慢性危重症的已知后遗症,这些多维病症可能与SARS-CoV-2特异性效应难以区分。
  • COVID-19急性期后遗症包括躯体、认知和精神健康损害,统称长COVID或COVID-19后状态。
  • 该多系统病症的负担在个体、医疗系统和社会经济层面达到前所未有的规模。
  • 研究需减少COVID-19相关重症急性期后遗症的发生,并优化治疗和康复照护和支持。

适用人群与场景

  • 成人COVID-19重症幸存者,即经历COVID-19相关危重症后的患者。

研究设计与关键结果

  • 综述成人COVID-19重症后急性期后遗症的表现,探讨对各器官系统的影响、潜在病理生理机制,以及为多系统表现的重症幸存者提供临床照护和支持的挑战。

证据类型、等级与局限

  • 证据类型:综述。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为研究需减少COVID-19相关重症急性期后遗症的发生,并优化治疗和康复照护和支持。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

Individuals with SARS-CoV-2 infection can develop symptoms that persist well beyond the acute phase of COVID-19 or emerge after the acute phase, lasting for weeks or months after the initial acute illness. The post-acute sequelae of COVID-19, which include physical, cognitive, and mental health impairments, are known collectively as long COVID or post-COVID-19 condition. The substantial burden of this multisystem condition is felt at individual, health-care system, and socioeconomic levels, on an unprecedented scale. Survivors of COVID-19-related critical illness are at risk of the well known sequelae of acute respiratory distress syndrome, sepsis, and chronic critical illness, and these multidimensional morbidities might be difficult to differentiate from the specific effects of SARS-CoV-2 and COVID-19. We provide an overview of the manifestations of post-COVID-19 condition after critical illness in adults. We explore the effects on various organ systems, describe potential pathophysiological mechanisms, and consider the challenges of providing clinical care and support for survivors of critical illness with multisystem manifestations. Research is needed to reduce the incidence of post-acute sequelae of COVID-19-related critical illness and to optimise therapeutic and rehabilitative care and support for patients.

来源:Lancet Respir Med,查看原文。版权归原作者所有。

参考来源

  1. Parotto M, Gyöngyösi M, Howe K, et al. Post-acute sequelae of COVID-19: understanding and addressing the burden of multisystem manifestations. Lancet Respir Med. 2023. PMID: 37475125. doi:10.1016/S2213-2600(23)00239-4

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。